<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>BRONXIAL  ASTMA  KASALLIGINI DAVOLASHDA   OMALIZUMAB  DORI VOSITASINI QO’LLASHNING AFZALLIGI</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Adxamov Asror Adxam</mods:namePart><mods:namePart type="family">o’g’li</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">X.R.</mods:namePart><mods:namePart type="family">Xasanova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Bronxial astma – bu surunkali yallig‘lanish bilan kechuvchi, havo yo‘llarining torayishi va giperreaktivligi bilan xarakterlanadigan&amp;nbsp;kasallikdir. Ayniqsa, allergik shakllarida immunologik mexanizmlar asosiy rol o‘ynaydi. Standart terapiya, jumladan inhalatsion kortikosteroidlar va beta-2 agonistlar ba’zida yetarli bo‘lmagan hollarda, yangi biologik davo usullariga ehtiyoj tug‘iladi.&amp;nbsp;</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-11-23</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>"Research Science and Innovation house" LLC</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>